RADT-24. HIGH ABSORBED DOSES OF RHENIUM-186 NANOLIPOSOMES (RNL) IN RECURRENT GBM: A PHASE 1 STUDY

INTRODUCTION: While external beam radiation therapy (EBRT) remains a central component of the management of primary brain tumors, it is limited by tolerance of the surrounding normal brain tissue. Nanoliposomal BMEDA-chelated-(186)Rhenium (RNL™) permits the delivery of beta-emitting radiation of hig...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Brenner, Andrew, Floyd, John, Bao, Ande, Phillips, William, Awasthi, Vibhudutta, Patel, Toral, Weinberg, Jeffrey
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Clinical Radiotherapy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651340/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.777
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia